v3.25.2
ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Schedule of Consideration for RayzeBio Acquisition (Details) - RayzeBio - USD ($)
$ in Millions
6 Months Ended
Feb. 26, 2024
Jun. 30, 2024
Business Combination [Line Items]    
Total consideration $ 4,147  
Total consideration allocated 3,873  
Common Stock    
Business Combination [Line Items]    
Total consideration 3,851  
Equity    
Business Combination [Line Items]    
Total consideration 296  
Unvested Equity Awards    
Business Combination [Line Items]    
Total consideration $ 274  
Unvested Equity Awards | Selling, general and administrative    
Business Combination [Line Items]    
Total consideration   $ 159
Unvested Equity Awards | Research and development    
Business Combination [Line Items]    
Total consideration   $ 115